top of page
News
Search
Renovion Announces Positive Top-Line Results from Phase 2 CLIMB Study of ARINA-1 (RVN-301) in Patients with Non-Cystic Fibrosis Bronchiectasis
Elevated QOL in NCFBE patients with ARINA-1 treatment. Robust data show significant symptom improvement surpassing clinical thresholds.
Renovion
Apr 30, 20245 min read
Renovion Completes Enrollment of Adult Patients in Phase 2 CLIMB Study in Bronchiectasis
Renovion Inc., a company focused on restoring lung health in patients with bronchiectasis, announces patient enrollment for Phase 2 trial.
Renovion
Jan 11, 20242 min read
Interview with the Lung Transplant Foundation: Participating in a Lung Transplant Clinical Trial
Carolyn Durham, CSO at Renovion and Amy S., ED at the LTx Foundation discuss real-world experience of being in a clinical trial in LTx.
Renovion
Oct 10, 20231 min read
Renovion Receives Notice of Study May Proceed Status for Lung Transplant Program
Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for serious chronic inflammatory lung diseases...
Renovion
Aug 2, 20222 min read
Renovion Provides Regulatory Update and Initiation of Clinical Program in Non-CF Bronchiectasis
Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare, chronic, and serious lung diseases...
Renovion
Apr 7, 20222 min read
bottom of page